US Stock MarketDetailed Quotes

MURA Mural Oncology

Watchlist
  • 3.180
  • +0.040+1.27%
Close Dec 20 16:00 ET
  • 3.160
  • -0.020-0.63%
Post 20:01 ET
54.25MMarket Cap-0.35P/E (TTM)

Mural Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-26.37%34.1M
-27.47%34.28M
-22.93%34.03M
6.12%196.24M
23.54%58.51M
-6.06%46.31M
47.26M
44.16M
5.45%184.92M
47.36M
Selling and administrative expenses
9.30%6.51M
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
14.05%17.73M
--4.97M
-General and administrative expense
9.30%6.51M
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
14.05%17.73M
--4.97M
Research and development costs
-31.64%27.59M
-35.23%27.54M
-33.51%26.87M
-0.99%165.53M
-0.36%42.24M
-9.87%40.35M
--42.53M
--40.41M
4.61%167.19M
--42.39M
Operating profit
26.37%-34.1M
27.47%-34.28M
22.93%-34.03M
-6.12%-196.24M
-23.54%-58.51M
6.06%-46.31M
-47.26M
-44.16M
-5.45%-184.92M
-47.36M
Net non-operating interest income expense
Other net income (expense)
2.34M
2.71M
3.12M
951K
Other non- operating income (expenses)
--2.34M
--2.71M
--3.12M
--951K
----
----
----
----
----
----
Income before tax
31.43%-31.76M
33.21%-31.56M
29.98%-30.92M
-5.60%-195.29M
-21.53%-57.56M
6.06%-46.31M
-47.26M
-44.16M
-5.45%-184.92M
-47.36M
Income tax
0
0
0
148.98%12.16M
61.89%1.98M
270.32%4.97M
2.91M
2.31M
7,082.35%4.88M
1.22M
Net income
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
Net income continuous Operations
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
---50.16M
---46.47M
-8.19%-189.81M
---48.58M
Minority interest income
Net income attributable to the parent company
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
38.07%-31.76M
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
Basic earnings per share
39.14%-1.87
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
-8.19%-11.3738
-2.9112
Diluted earnings per share
39.14%-1.87
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
-8.19%-11.3738
-2.9112
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -26.37%34.1M-27.47%34.28M-22.93%34.03M6.12%196.24M23.54%58.51M-6.06%46.31M47.26M44.16M5.45%184.92M47.36M
Selling and administrative expenses 9.30%6.51M42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M14.05%17.73M--4.97M
-General and administrative expense 9.30%6.51M42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M14.05%17.73M--4.97M
Research and development costs -31.64%27.59M-35.23%27.54M-33.51%26.87M-0.99%165.53M-0.36%42.24M-9.87%40.35M--42.53M--40.41M4.61%167.19M--42.39M
Operating profit 26.37%-34.1M27.47%-34.28M22.93%-34.03M-6.12%-196.24M-23.54%-58.51M6.06%-46.31M-47.26M-44.16M-5.45%-184.92M-47.36M
Net non-operating interest income expense
Other net income (expense) 2.34M2.71M3.12M951K
Other non- operating income (expenses) --2.34M--2.71M--3.12M--951K------------------------
Income before tax 31.43%-31.76M33.21%-31.56M29.98%-30.92M-5.60%-195.29M-21.53%-57.56M6.06%-46.31M-47.26M-44.16M-5.45%-184.92M-47.36M
Income tax 000148.98%12.16M61.89%1.98M270.32%4.97M2.91M2.31M7,082.35%4.88M1.22M
Net income 38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M
Net income continuous Operations 38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M---50.16M---46.47M-8.19%-189.81M---48.58M
Minority interest income
Net income attributable to the parent company 38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 38.07%-31.76M37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M
Basic earnings per share 39.14%-1.8738.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844-8.19%-11.3738-2.9112
Diluted earnings per share 39.14%-1.8738.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844-8.19%-11.3738-2.9112
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.